Persistent disparities in liver transplantation for patients with hepatocellular carcinoma in the United States, 1998 through 2007
β Scribed by Anthony S. Robbins; Derrick D. Cox; Lynt B. Johnson; Elizabeth M. Ward
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 148 KB
- Volume
- 117
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
BACKGROUND:
Prior studies have demonstrated that among patients with hepatocellular carcinoma (HCC), African Americans (AAs) and Asian/Pacific Islanders (APIs) are substantially less likely to undergo liver transplantation (LT) compared with whites. The authors examined whether disparities in the receipt of LT among LTβeligible HCC patients changed over a 10βyear time period, and whether the disparities might be explained by sociodemographic or clinical factors.
METHODS:
The National Cancer Data Base, a national hospitalβbased cancer registry, was used to study 7707 adults with small (β€ 5 cm), nonmetastatic HCC diagnosed between 1998 and 2007. Racial/ethnic patterns in the use of LT were compared during 2 periods of 5 years each: 1998 through 2002 (n = 2412 patients) and 2003 through 2007 (n = 5295 patients). Data regarding comorbid medical conditions were only available during the later time period.
RESULTS:
Large and persistent racial/ethnic differences in the probability of receiving LT were observed. Compared with whites, hazard ratios (HRs) and associated 95% confidence intervals (95% CIs) for receiving LT from 1998 through 2002 were 0.64 (95% CI, 0.46β0.89) for AA patients, 1.01 (95% CI, 0.79β1.29) for Hispanic patients, and 0.52 (95% CI, 0.39β0.68) for API patients. Analogous results for 2003 through 2007 were 0.64 (95% CI, 0.54β0.76) for AA patients, 0.86 (95% CI, 0.75β0.99) for Hispanic patients, and 0.58 (95% CI, 0.49β0.69) for API patients. AA patients were less likely than whites to undergo any form of surgery, and API patients were more likely than whites to undergo surgical resection. Adjustment for sociodemographic and clinical factors produced only small changes in these HRs.
CONCLUSIONS:
Between 1998 and 2007, there were large and persistent racial/ethnic disparities noted in the receipt of LT among patients with HCC. These disparities were not explained by sociodemographic or clinical factors. Cancer 2011;. Β© 2011 American Cancer Society.
π SIMILAR VOLUMES
A national conference was held to better characterize the long-term outcomes of liver transplantation (LT) for patients with hepatocellular carcinoma (HCC) and to assess whether it is justified to continue the policy of assigning increased priority for candidates with early-stage HCC on the transpla
Surveillance for hepatocellular carcinoma (HCC) in patients with cirrhosis is recommended but may not be performed. The extent and determinants of HCC surveillance are unknown. We conducted a population-based United States cohort study of patients over 65 years of age to examine use and determinants
Hepatocellular carcinoma (HCC) is a common indication for liver transplantation (LT). Currently, deceased donor LT is approved by the United Network for Organ Sharing for patients with HCC who meet the Milan criteria of a single tumor up to 5 cm or up to 3 tumors up to 3 cm as determined by imaging
Objective: To evaluate the feasibility and postoperative course of liver transplantation (LT) in cirrhotic patients who underwent liver resection prior to LT for HCC. Summary Background Data: Although LT provides longer survival than liver resection for treatment of small HCCs, donor shortage and lo